Abstract: A method quantitatively analyzes images of two different cell types that interact in producing and maintaining a disease state or other biological condition. The two separate cell types are exposed to an agent or stimulus suspected of influencing the biological condition (e.g., the agent might be a potential therapeutic for treating a cancer). The two different cell types are co-cultured or otherwise allowed to interact with one another before and during exposure to the agent. The images of the cells show how the agent affects the cells' phenotypes, including their viability, migration patterns, etc. The method generates a quantitative phenotype for each cell type by quantitatively analyzing the cell images via an automatic procedure. The quantitative phenotypes typically take the form of a group of scalar or vector descriptors that together provide a “fingerprint.” The descriptors may be size values, positions, morphological values, intensity distributions, etc.
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif2x, antibodies to HsKif2x, methods of screening for HsKif2x modulators using biologically active HsKif2x, and kits for screening for HsKif2x modulators.
Abstract: The present invention provides high throughput screening systems for identifying compounds that modulate the biological activity of a biochemically functional sarcomere. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
Type:
Grant
Filed:
November 28, 2000
Date of Patent:
June 3, 2003
Assignee:
Cytokinetics, Inc.
Inventors:
James J. Hartman, Fady Malik, Roman Sakowicz, Jeffrey T. Finer
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif7, antibodies to HsKif7, methods of screening for HsKif7 modulators using biologically active HsKif7, and kits for screening for HsKif7 modulators.
Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
Type:
Grant
Filed:
November 28, 2000
Date of Patent:
May 13, 2003
Assignee:
Cytokinetics, Inc.
Inventors:
Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif7, antibodies to HsKif7, methods of screening for HsKif7 modulators using biologically active HsKif7, and kits for screening for HsKif7 modulators.
Abstract: The present invention provides high throughput screening systems for identifying compounds useful in the treatment of cellular proliferation disorders. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
Abstract: Described herein are methods of producing kinesins. In a preferred embodiment, the kinesins are produced from a prokaryote, most preferably, a bacterial cell. Bacterial expression offers several advantages over systems previously utilized, such as, for example, Bacculovirus. The yield of protein is higher, the cost of the expression setup is lower, and creation of alternative expression vectors is easier. The concern of copurifying a contaminating activity from the expression host is also eliminated since bacteria, in contrast to the bacculovirus expression system, do not have kinesin like proteins. Also described herein are purified kinesins, preferably unglycosylated and methods of use.
Type:
Grant
Filed:
June 16, 2000
Date of Patent:
April 8, 2003
Assignee:
Cytokinetics, Inc.
Inventors:
Christophe Beraud, Cara Ohashi, Roman Sakowicz, Eugeni Vaisberg, Ken Wood, Ming Yu
Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
Type:
Grant
Filed:
October 24, 2000
Date of Patent:
April 8, 2003
Assignee:
Cytokinetics, Inc.
Inventors:
Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKip3d, antibodies to HsKip3d, methods of screening for HsKip3d modulators using biologically active HsKip3d, and kits for screening for HsKip3d modulators.
Abstract: The present invention provides high throughput screening systems for identifying compounds that modulate the biological activity of a biochemically functional sarcomere. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
Type:
Grant
Filed:
March 29, 2000
Date of Patent:
December 17, 2002
Assignee:
Cytokinetics, Inc.
Inventors:
James J. Hartman, Fady Malik, Roman Sakowicz, Jeffrey T. Finer
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif6, antibodies to HsKif6, methods of screening for HsKif6 modulators using biologically active HsKif6, and kits for screening for HsKif6 modulators.
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKip3d, antibodies to HsKip3d, methods of screening for HsKip3d modulators using biologically active HsKip3d, and kits for screening for HsKip3d modulators.
Abstract: The present invention provides high throughput screening systems for identifying antifungal compounds. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
Type:
Grant
Filed:
November 28, 2000
Date of Patent:
October 22, 2002
Assignee:
Cytokinetics, Inc.
Inventors:
Corey E. Nislow, Roman Sakowicz, Christophe Beraud
Abstract: The invention provides isolated nucleic acid and amino acid sequences of AL353662, antibodies to AL353662, methods of screening for AL353662 modulators using biologically active AL353662, and kits for screening for AL353662 modulators.
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif21b, antibodies to HsKif21b, methods of screening for HsKif21b modulators using biologically active HsKif21b, and kits for screening for HsKif21b modulators.
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKrp5, antibodies to HsKrp5, methods of screening for HsKrp5 modulators using biologically active HsKrp5, and kits for screening for HsKtp5 modulators.
Abstract: The present invention provides high throughput screening systems for identifying compounds useful in the treatment of cellular proliferation disorders. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
Type:
Grant
Filed:
June 15, 2000
Date of Patent:
September 10, 2002
Assignee:
Cytokinentics, Inc.
Inventors:
Eugeni A. Vaisberg, Kenneth W. Wood, Christophe Beraud
Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKrp5, antibodies to HsKrp5, methods of screening for HsKrp5 modulators using biologically active HsKrp5, and kits for screening HsKrp5 modulators.
Abstract: The present invention provides high throughput screening systems for identifying compounds useful in the treatment of cellular proliferation disorders. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.
Type:
Grant
Filed:
June 12, 2000
Date of Patent:
August 27, 2002
Assignee:
Cytokinetics, Inc.
Inventors:
Christophe Beraud, Jeffrey T. Finer, Roman Sakowicz, Kenneth W. Wood